美国健康网
CNC
69.16
-1.35
-1.91%
美国健康网
US · CNC
#663 按市值排名
上市于 1970
69.16
-1.35
-1.91%
实时 - 追踪5344个代码 - 心跳于561秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 99.67% -0.15pp
- 机构数量
- 1,210
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund73.56%
Hedge Fund15.13%
Public Company2.97%
Government Pension Fund2.68%
Private Company2.36%
Sovereign Wealth Fund1.82%
Family Office/Trust0.63%
Individual/Insider0.35%
Insurance Company0.26%
Other0.26%
主要股东 截至 2026-06-30
BlackRock
8.39% · 41.45M 股
Vanguard Capital Management, LLC
6.91% · 34.14M 股
AQR Capital Management
5.70% · 28.15M 股
Vanguard Portfolio Management, LLC
4.52% · 22.35M 股
State Street Global Advisors
4.45% · 21.97M 股
Geode Capital Management, LLC
2.69% · 13.31M 股
Wellington Management Group
2.69% · 13.30M 股
Columbia Management Investment Advisers, LLC
2.51% · 12.42M 股
Harris Associates L.P.
2.25% · 11.12M 股
T. Rowe Price Group, Inc.
1.76% · 8.70M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 29次买入 · 15次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Frederick Eppinger | Independent Chairperson | 0.07% |
| Andrew Asher | Chief Financial Officer | 0.06% |
| Sarah London | Chief Executive Officer | 0.06% |
| Kenneth Burdick | Director | 0.06% |
| Kenneth Fasola | President | 0.02% |
| Theodore Samuels | Independent Director | 0.01% |
| H. Dallas | Lead Independent Director | 0.01% |
| Christopher Coughlin | Independent Director | 0.01% |
| Katie Casso | Senior VP, Chief Accounting Office & Corporate Controller | 0.01% |
| Susan Smith | Chief Operating Officer | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Lauren Tyler | Director | Other Acquisition | +482 | -- |
| 2026-09-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +864 | -- |
| 2026-09-29 | Christopher Coughlin | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Theodore Samuels | Independent Director | Other Acquisition | +583 | -- |
| 2026-09-29 | Kenneth Tanji | Director | Other Acquisition | +603 | -- |
| 2026-09-14 | Theodore Pienkos | Corporate Controller & Chief Accounting Officer | Sale to Issuer | -1,092 | $69.41 |
| 2026-08-25 | Kenneth Burdick | Director | Intent to Sell (Form 144) | -43,600 | $65.00 |
| 2026-08-25 | Christopher Koster | General Counsel | Open Market Disposition | -56,500 | $66.90 |
| 2026-08-17 | Christopher Koster | General Counsel | Open Market Disposition | -47,603 | $65.36 |
| 2026-08-04 | Kenneth Burdick | Director | Intent to Sell (Form 144) | -100,000 | $68.15 |
| 2026-07-27 | Paul Diaz | Director | Other Acquisition | +2,771 | -- |
| 2026-07-16 | Lauren Tyler | Director | Other Acquisition | +3,155 | -- |
| 2026-06-29 | Lauren Tyler | Director | Other Acquisition | +61 | -- |
| 2026-06-29 | Frederick Eppinger | Independent Chairperson | Other Acquisition | +833 | -- |
| 2026-06-29 | Christopher Coughlin | Independent Director | Other Acquisition | +562 | -- |
| 2026-06-29 | Theodore Samuels | Independent Director | Other Acquisition | +465 | -- |
| 2026-06-29 | Kenneth Tanji | Director | Other Acquisition | +581 | -- |
| 2026-06-14 | Susan Smith | Chief Operating Officer | Sale to Issuer | -483 | $65.19 |
| 2026-06-09 | Kenneth Burdick | Director | Open Market Disposition | -80,000 | $64.55 |
| 2026-05-28 | Michael Carson | President & CEO of Medical Business | Derivative Disposition Under Emp | -604 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
美国健康网 讨论区 0 条评论